[1]Hoffman,RobertL.;Kania,RobertS.;Brothers,MaryA.;Davies,JayF.;Ferre,RoseA.;Gajiwala,KetanS.;He,Mingying;Hogan,RobertJ.;Kozminski,Kirk;Li,LilianY.;Lockner,JonathanW.;Lou,Jihong;Marra,MichelleT.;Mitchell,LennertJ.;Murray,BrionW.;Nieman,JamesA.;Noell,Stephen;Planken,SimonP.;Rowe,Thomas;Ryan,Kevin;Smith,GeorgeJ.;Solowiej,JamesE.;Steppan,ClaireM.;Taggart,Barbara[JournalofMedicinalChemistry,2020,vol.63,#21,p.12725-12747]
[2]CurrentPatentAssignee:PFIZERINC-WO2021/176369,2021,A1
[3]CurrentPatentAssignee:COCRYSTALPHARMA,INC.-WO2021/206876,2021,A1Locationinpatent:Paragraph001354;001362-001363
[4]CurrentPatentAssignee:SORRENTOTHERAPEUTICSINC-WO2022/256434,2022,A1
[1]Hoffman,RobertL.;Kania,RobertS.;Brothers,MaryA.;Davies,JayF.;Ferre,RoseA.;Gajiwala,KetanS.;He,Mingying;Hogan,RobertJ.;Kozminski,Kirk;Li,LilianY.;Lockner,JonathanW.;Lou,Jihong;Marra,MichelleT.;Mitchell,LennertJ.;Murray,BrionW.;Nieman,JamesA.;Noell,Stephen;Planken,SimonP.;Rowe,Thomas;Ryan,Kevin;Smith,GeorgeJ.;Solowiej,JamesE.;Steppan,ClaireM.;Taggart,Barbara[JournalofMedicinalChemistry,2020,vol.63,#21,p.12725-12747]
[1]Hoffman,RobertL.;Kania,RobertS.;Brothers,MaryA.;Davies,JayF.;Ferre,RoseA.;Gajiwala,KetanS.;He,Mingying;Hogan,RobertJ.;Kozminski,Kirk;Li,LilianY.;Lockner,JonathanW.;Lou,Jihong;Marra,MichelleT.;Mitchell,LennertJ.;Murray,BrionW.;Nieman,JamesA.;Noell,Stephen;Planken,SimonP.;Rowe,Thomas;Ryan,Kevin;Smith,GeorgeJ.;Solowiej,JamesE.;Steppan,ClaireM.;Taggart,Barbara[JournalofMedicinalChemistry,2020,vol.63,#21,p.12725-12747]
[1]Hoffman,RobertL.;Kania,RobertS.;Brothers,MaryA.;Davies,JayF.;Ferre,RoseA.;Gajiwala,KetanS.;He,Mingying;Hogan,RobertJ.;Kozminski,Kirk;Li,LilianY.;Lockner,JonathanW.;Lou,Jihong;Marra,MichelleT.;Mitchell,LennertJ.;Murray,BrionW.;Nieman,JamesA.;Noell,Stephen;Planken,SimonP.;Rowe,Thomas;Ryan,Kevin;Smith,GeorgeJ.;Solowiej,JamesE.;Steppan,ClaireM.;Taggart,Barbara[JournalofMedicinalChemistry,2020,vol.63,#21,p.12725-12747]
[2]CurrentPatentAssignee:SCRIPPSRESEARCH-WO2022/261473,2022,A1
[1]CurrentPatentAssignee:PFIZERINC-WO2021/176369,2021,A1Locationinpatent:Paragraph43
[2]Hoffman,RobertL.;Kania,RobertS.;Brothers,MaryA.;Davies,JayF.;Ferre,RoseA.;Gajiwala,KetanS.;He,Mingying;Hogan,RobertJ.;Kozminski,Kirk;Li,LilianY.;Lockner,JonathanW.;Lou,Jihong;Marra,MichelleT.;Mitchell,LennertJ.;Murray,BrionW.;Nieman,JamesA.;Noell,Stephen;Planken,SimonP.;Rowe,Thomas;Ryan,Kevin;Smith,GeorgeJ.;Solowiej,JamesE.;Steppan,ClaireM.;Taggart,Barbara[JournalofMedicinalChemistry,2020,vol.63,#21,p.12725-12747]
[3]CurrentPatentAssignee:SORRENTOTHERAPEUTICSINC-WO2022/256434,2022,A1Locationinpatent:Paragraph00272-00273
[4]CurrentPatentAssignee:SORRENTOTHERAPEUTICSINC-WO2022/256434,2022,A1Locationinpatent:Paragraph00272-00273
[5]CurrentPatentAssignee:SORRENTOTHERAPEUTICSINC-WO2022/256434,2022,A1Locationinpatent:Paragraph00272-00273
Title: Robert L Hoffman, et al. Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19. J Med Chem. 2020 Nov 12;63(21):12725-12747.
